Navigation Links
Internal Fixation Systems, Inc. Receives FDA 510(k) Clearance to Market Fixation Devices to Treat Bone Fractures and Osteotomies
Date:9/14/2011

MIAMI, Sept. 14, 2011 /PRNewswire/ -- Internal Fixation Systems, Inc. (OTC QB: IFIX) today announces that it has received U.S. Food and Drug Administration (FDA) clearance to market its bone fixation devices that include various plates, screws, and washers used to treat bone fractures and osteotomies.

The 510(k) clearance authorizes IFS to market a line of locking plates which includes mini-fragment, small fragment, and large fragment systems.  The initial system, a modular locking small fragment set, should be available for sale during the 4th quarter 2011.

"The comprehensive family of locking plate products will allow us to compete in the rapidly growing US orthopedic fracture fixation market," says Ken West, Founder and Vice President of Sales.  "IFS's enhanced products and responsible pricing should position the company well in this competitive market."

"The locking small fragment system is the first step in the build-out of our complete line of orthopedic implants," according to Christopher D. Endara, Founder and Vice President of Engineering, Operations, Quality, and Regulatory Affairs.

"The approval of these devices will benefit patients and surgeons by providing high quality, cost effective alternatives critical in today's healthcare environment," said Internal Fixation Systems President and CEO, Stephen Dresnick, MD. Over the last 18 months, we have developed several new product lines and are developing the infrastructure to grow."

About IFS:  Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants.  We seek to prove that superior products and lower costs can go hand in hand.  IFS focuses on widely used, market proven products used to treat common fractures.  Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs.  The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition.  IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons.  Please contact us for more information about our product and business model.This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events.  Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as the statements that Internal Fixation anticipates the launch of the locking plate and screw systems   There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including whether Internal Fixation will have sufficient capital to continue its operations..  Actual results and future events could differ materially from those anticipated in such information.  These and all subsequent written and oral forward-looking information are based on estimates and views of  management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS does not intend to update these forward-looking statements.For further information, please contact:

Laura Cattabriga, Chief Financial OfficerTel: 786 268 0995Laura.cattabriga@ifsusa.net
'/>"/>

SOURCE Internal Fixation Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
2. Building Support for a New Product Through Effective Internal Disease State Communication
3. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
4. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
5. Maximizing the Potential of Internal and External Communications Groups
6. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
7. SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
8. Toriseva Law and Karon & Dalimonte LLP: Archives of Internal Medicine Article Faults Manufacturers of IVC Filters
9. Corporate Affairs Role in Internal and External Relationships Key to Organizational Success
10. International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network
11. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
Breaking Medicine News(10 mins):